| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Revenue | $2.26B | -16.1% |
| Cost of Revenue | $1.97B | -16.6% |
| Gross Profit | $295.8M | -13.3% |
| R&D Expense | $86.2M | +30.2% |
| SG&A Expense | $163.1M | -5.7% |
| Interest Expense | $500K | -87.8% |
| Pre-tax Income | -$45.1M | -213.9% |
| Income Tax | $22.9M | +148.9% |
| Net Income | -$48.3M |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $690.8M | +54.0% |
| Accounts Receivable | $272.8M | +26.0% |
| Inventory | $455.0M | +149.2% |
| Current Assets | $2.06B | +22.8% |
| Total Assets | $2.36B | +23.9% |
| Current Liabilities | $1.37B | +8.9% |
| Total Liabilities | $1.81B | +39.6% |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$145.5M | -282.6% |
| Capital Expenditures | $14.9M | +83.4% |
| Investing Cash Flow | -$29.8M | -57.0% |
| Financing Cash Flow | $356.9M | +4213.4% |
| Free Cash Flow | -$160.4M | -324.1% |
| -312.7% |
| EPS (Basic) | -$0.37 | -305.6% |
| EPS (Diluted) | -$0.37 | -384.6% |
| Stockholders' Equity |
| $429.6M |
| -9.0% |